Back to Search
Start Over
P2.19-01 First-in-Human Phase 1 Trial of VT3989, a First-in-Class YAP/TEAD Inhibitor in Patients with Advanced Mesothelioma
- Source :
- Journal of Thoracic Oncology; November 2023, Vol. 18 Issue: 11, Number 11 Supplement 1 pS384-S384, 1p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 15560864 and 15561380
- Volume :
- 18
- Issue :
- 11, Number 11 Supplement 1
- Database :
- Supplemental Index
- Journal :
- Journal of Thoracic Oncology
- Publication Type :
- Periodical
- Accession number :
- ejs64381830
- Full Text :
- https://doi.org/10.1016/j.jtho.2023.09.680